| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531392 | International Immunopharmacology | 2018 | 10 Pages |
Abstract
These results are highly relevant for the use of common peptides among the different isoforms of hMena to develop immunotherapy protocols to counteract the growth and metastatic potential of tumors with over-expression of hMena.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Christian Azucena Don-López, Alberto Monroy-GarcÃa, Benny Weiss-Steider, Leticia Rocha-Zavaleta, Jorge Hernández-Montes, Rosario GarcÃa-Rocha, MarÃa de Lourdes Mora-GarcÃa,